Henry Schein, Inc. (NASDAQ:HSIC) Receives $79.30 Consensus PT from Brokerages

Henry Schein, Inc. (NASDAQ:HSIC) has received a consensus recommendation of “Moderate Buy” from the eleven analysts that are presently covering the company, MarketBeat.com reports. Five analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $79.30.

A number of research analysts have recently weighed in on HSIC shares. Piper Sandler cut their price objective on Henry Schein from $83.00 to $77.00 and set an “overweight” rating for the company in a research report on Wednesday, April 30th. Wells Fargo & Company dropped their price target on Henry Schein from $80.00 to $75.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 6th. UBS Group dropped their price target on Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research report on Wednesday, February 26th. Jefferies Financial Group lifted their price target on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. Finally, Barrington Research dropped their price target on Henry Schein from $90.00 to $86.00 and set an “outperform” rating for the company in a research report on Tuesday, May 6th.

Henry Schein Trading Up 0.7%

Shares of HSIC stock opened at $72.05 on Friday. The firm has a market capitalization of $8.77 billion, a PE ratio of 29.65, a PEG ratio of 2.13 and a beta of 0.87. The stock has a fifty day simple moving average of $67.34 and a two-hundred day simple moving average of $71.47. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein has a 52-week low of $60.56 and a 52-week high of $82.49.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, beating analysts’ consensus estimates of $1.11 by $0.04. The firm had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business’s quarterly revenue was down .1% compared to the same quarter last year. During the same quarter last year, the business posted $1.10 earnings per share. On average, analysts predict that Henry Schein will post 4.74 EPS for the current fiscal year.

Insiders Place Their Bets

In other Henry Schein news, Director Philip A. Laskawy sold 2,604 shares of the firm’s stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the sale, the director now owns 24,805 shares of the company’s stock, valued at $1,762,147.20. This trade represents a 9.50% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the sale, the chief executive officer now directly owns 62,688 shares of the company’s stock, valued at $4,460,251.20. This represents a 6.05% decrease in their position. The disclosure for this sale can be found here. 1.08% of the stock is owned by insiders.

Institutional Trading of Henry Schein

Several institutional investors and hedge funds have recently modified their holdings of the stock. Smartleaf Asset Management LLC raised its stake in shares of Henry Schein by 23.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock valued at $52,000 after acquiring an additional 143 shares in the last quarter. Guggenheim Capital LLC raised its stake in Henry Schein by 2.5% in the fourth quarter. Guggenheim Capital LLC now owns 6,428 shares of the company’s stock worth $445,000 after buying an additional 159 shares in the last quarter. CIBC Asset Management Inc raised its stake in Henry Schein by 1.0% in the fourth quarter. CIBC Asset Management Inc now owns 17,849 shares of the company’s stock worth $1,235,000 after buying an additional 169 shares in the last quarter. Metis Global Partners LLC raised its stake in Henry Schein by 4.7% in the fourth quarter. Metis Global Partners LLC now owns 4,203 shares of the company’s stock worth $291,000 after buying an additional 187 shares in the last quarter. Finally, UMB Bank n.a. raised its stake in Henry Schein by 23.2% in the first quarter. UMB Bank n.a. now owns 1,066 shares of the company’s stock worth $73,000 after buying an additional 201 shares in the last quarter. Institutional investors own 96.62% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.